lunes, 12 de octubre de 2026
White Papers (+++)
Advancing biological imaging with submicron IR
Biological analysis is dealing with a persistent gap in understanding: the tools used to reveal molecular chemistry rarely resolve it in space.
For example, though infrared spectroscopy can identify functional defects without labels, its diffraction is limited to several micrometers, which is too coarse for subcellular detail. Raman spectroscopy, unlike infrared, reaches sub-micrometer resolution but is hindered by weak signals and fluorescence backgrounds in biological specimens.
https://www.news-medical.net/whitepaper/20261012/Advancing-biological-imaging-with-submicron-IR.aspx
Tracking lipid metabolism with submicron IR
It is well documented that saturated fatty acids are more toxic than unsaturated ones. However, the underlying mechanism remains unresolved because it is extremely difficult to visualize the subcellular chemical conversions at the root of lipotoxicity, the lipid accumulation that leads to cell death and metabolic diseases such as MASLD, in living cells.
For researchers investigating lipid metabolism and liver disease, it is vital to make the connection between fatty acid chemistry and specific organelles. To better understand this long-standing research gap, researchers at Yale University have set out to investigate how saturated palmitic acid (PA) drives lipotoxicity.
https://www.news-medical.net/whitepaper/20261009/Tracking-lipid-metabolism-with-submicron-IR.aspx
Microfluidics is transforming early-stage nanoparticle formulation for drug delivery
The rapid evolution of nanomedicine has elevated drug delivery from a formulation challenge to a critical factor determining therapeutic success. Whether developing mRNA vaccines, cancer therapeutics, or targeted gene therapies, researchers must balance particle size, encapsulation efficiency, and reproducibility, all while accelerating development timelines.
Microfluidic technologies are emerging as a powerful solution to these challenges. By enabling precise control over nanoparticle formation, they offer researchers a faster and more reproducible alternative to conventional formulation methods. Combined with ready-to-use formulation kits, these platforms are making sophisticated nanoparticle development more accessible for laboratories across academia and industry.
https://www.news-medical.net/whitepaper/20261009/Microfluidics-is-transforming-drug-delivery-from-discovery-to-scalable-manufacturing.aspx
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario